3652 results for «303»

Filter By

3652 results

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Secondary mitral regurgitation: challenges in management

28 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.

Secondary mitral regurgitation: challenges in management

How should I treat a patient with multivessel disease - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.

How should I treat a patient with multivessel disease - A patient's journey

Transcatheter tricuspid valve interventions: outcomes

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations to learn how to better assess transcatheter tricuspid valve interventions results, to understand what are the endpoints after interventions as well as to learn what we can expect in future guidelines.

Transcatheter tricuspid valve interventions: outcomes

Multiple VHD: a diagnostic and clinical challenge

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.

Multiple VHD: a diagnostic and clinical challenge

Imaging before and after TAVI - How to treat

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.

Imaging before and after TAVI - How to treat

Where are we going? The symptomatic patient with moderate aortic stenosis

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.

Where are we going? The symptomatic patient with moderate aortic stenosis

Diagnosis of disease type and of disease severity

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.

Diagnosis of disease type and of disease severity

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?